Aaron Kimball - Apr 1, 2022 Form 4 Insider Report for Zymergen Inc. (ZY)

Role: Chief Technology Officer
Signature: /s/ Natalie Dement, attorney-in-fact
Stock symbol: ZY
Transactions as of: Apr 1, 2022
Transactions value $: -$93,551
Form type: 4
Date filed: 4/5/2022, 05:15 PM
Previous filing: Mar 3, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZY	Common Stock	Sale	-$71.1K	-25K	-3.35%	$2.84	720K	Apr 1, 2022	Direct	F1, F2
transaction	ZY	Common Stock	Sale	-$22.5K	-7.64K	-1.06%	$2.94	713K	Apr 1, 2022	Direct	F3, F4

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Aaron Kimball is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
F2	Transaction executed in multiple trades at prices ranging from $2.77 to $2.91 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	The shares were sold to cover the tax obligation that occurred upon the vesting of certain RSUs.
F4	Transaction executed in multiple trades at prices ranging from $2.93 to $3.00 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.